A QSAR Study on a Series of Indolin-2-Ones Acting as Non-Receptor Src Tyrosine Kinase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|8|10|918-925

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.8, Iss.10, 2011-12, pp. : 918-925

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A QSAR Study on Some Series of Anticancer Tyrosine Kinase Inhibitors

By  

Medicinal Chemistry, Vol. 9, Iss. 2, 2013-03 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the Non-Receptor Tyrosine Kinase Fes in Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2913-2920

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer

By Klempner Samuel J   Myers Andrea P   Mills Gordon B   Westin Shannon N  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2171-2182

Informa Healthcare

Access to resources Recommend Favorite

A QSAR Study on a Series of Pyrrole Derivatives Acting as Lymphocyte- Specific Kinase (Lck) Inhibitors

By  

Medicinal Chemistry, Vol. 8, Iss. 4, 2012-07 ,pp. : 649-655

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Molecular Docking Studies on a Series of 1-Amino-5H-pyrido [4, 3-b]indol-4-carboxamides Acting as Janus Kinase 2 (JAK2) Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 15, Iss. 2, 2018-01 ,pp. : 169-180

Bentham Science Publishers

Access to resources Recommend Favorite